A large-scale assessment of a smartwatch to identify atrial fibrillation (AF) during typical use, known as the Apple Health Study, has shown that the probability of receiving a digital alert of an irregular pulse is low, although more than four-fifths of the sent notifications are concordant with AF.
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.
Bicuspid and tricuspid aortic valve patients have comparable 30-day and 1-year mortality outcomes after transcatheter aortic valve replacement (TAVR), reports a recent meta-analysis. Rates of stroke and new pacemaker implants are likewise similar.
It is never too late to observe a healthy way of life. According to a recent study, adopting a healthy diet and lifestyle at mid-life can still lead to a longer life expectancy free of major chronic diseases.
A left ventricular ejection fraction (LVEF) cut-off of 60 percent may identify patients with heart failure (HF) with mid-range or preserved ejection fraction (mrEF or pEF) who could benefit from drug therapy.
Target organ damage appears to be more noticeable in patients affected by primary aldosteronism than those affected by arterial hypertension without primary aldosteronism, suggests a study, adding that specific treatment can ease such condition.